TP53 and neoplasm: A high frequency of mutations in tumor suppressors, including TP53 and RB1, with concurrent NOTCH1 computations were reported here in addition to both missense mutations and deletions in KMT2C in OA and extraocular sebaceous carcinomas, respectively.